Your browser doesn't support javascript.
loading
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial.
Henderson, Catherine; Knapp, Martin; Stirling, Susan; Shepstone, Lee; High, Juliet; Ballard, Clive; Bentham, Peter; Burns, Alistair; Farina, Nicolas; Fox, Chris; Fountain, Julia; Francis, Paul; Howard, Robert; Leroi, Iracema; Livingston, Gill; Nilforooshan, Ramin; Nurock, Shirley; O'Brien, John T; Price, Annabel; Swart, Ann Marie; Tabet, Naji; Telling, Tanya; Thomas, Alan J; Banerjee, Sube.
  • Henderson C; Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.
  • Knapp M; Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.
  • Stirling S; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Shepstone L; Norwich Medical School, University of East Anglia, Norwich, UK.
  • High J; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Ballard C; College of Medicine and Health, University of Exeter, Exeter, UK.
  • Bentham P; Birmingham and Solihull Mental Health Foundation NHS Trust, Birmingham, UK.
  • Burns A; University of Manchester, Manchester, UK.
  • Farina N; Centre for Dementia Studies, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
  • Fox C; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Fountain J; Research & Development Department, Sussex Partnership NHS Foundation Trust, Sussex Education Centre, Hove, UK.
  • Francis P; College of Medicine and Health, University of Exeter, Exeter, UK.
  • Howard R; Division of Psychiatry, University College London, London, UK.
  • Leroi I; Department of Psychiatry, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
  • Livingston G; Division of Psychiatry, University College London, London, UK.
  • Nilforooshan R; Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, UK.
  • Nurock S; Alzheimer's Society Research Network, UK.
  • O'Brien JT; Department of Psychiatry, University of Cambridge School of Medicine, Cambridge, UK.
  • Price A; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Swart AM; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Tabet N; Centre for Dementia Studies, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
  • Telling T; Joint Clinical Research Office, University of Sussex, Brighton, UK.
  • Thomas AJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Banerjee S; Faculty of Health, University of Plymouth, Plymouth, UK.
Int Psychogeriatr ; 34(10): 905-917, 2022 10.
Article en En | MEDLINE | ID: mdl-35852256

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Demencia Tipo de estudio: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Demencia Tipo de estudio: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article